This book tackles the debate over nanotechnology's environmental, health and safety (EHS) by thoroughly explaining EHS issues, financial implications, foreseeable risks (i.e. exposure, dose, hazards of nanomaterials), and the implications of occupational hygiene precautions and consumer protections.
Real-world case studies are included, e.g. the discussion of a leading chemical company's unusual pairing with the USA's largest environmental NGO, and an innovative program designed for small- to mid-sized businesses, which became a model approach for proactive nanotechnology EHS risk management.
· Considers the potential of nanotechnology from multiple perspectives (NGO, insurance industry, small business, etc)
· Provides guidance and advice for appropriate, proactive risk management strategies
· Reviews toxicological studies and industrial initiatives, documented with actual case studies
· Of significant interest to CEOs/CTOs of technology companies (SMEs), Health and Safety officers of technology companies (SMEs), Government officials (HSE), Toxicology experts, and venture capitalists
SECTION 1: Risks: What are Some of the Risks?
1. Toxicological studies with nanoscale materials
2. Are we willing to heed the lessons of the past? Nanomaterials and Australia's asbestos legacy
SECTION 2: Regulation: How are they Currently Regulated?
3. Global perspectives on the oversight of nanotechnologies
4. A nanotechnology legal framework
SECTION 3: Management: What is Being Done to Manage them?
5. Nanotechnology risk management: An insurance industry perspective
6. Industry-led initiative for occupational health and safety
7. Nanotechnology risk management and small business: A case study on the nanosafe framework
8. A case study of a nanoscale-research facility safety through design and operation